Screener
Sionna Therapeutics SION EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from Sionna Therapeutics’s reported figures.
The source filing: Sionna Therapeutics’s 10-Q, filed May 12, 2026. Open the filing →
- Filed
- May 12, 2026, 7:17 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-033876
FAQ
- What is Sionna Therapeutics's EBITDA?
- Sionna Therapeutics (SION) reported EBITDA of -$29.45M in Q1 2026.
- How has Sionna Therapeutics's EBITDA changed year-over-year?
- Sionna Therapeutics's EBITDA decreased by 51.0% year-over-year, from -$19.5M to -$29.45M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.
Ask your AI about Sionna Therapeutics's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude